The FDA has announced the approval of the world’s first-ever Ebola vaccine called Ervebo, which is developed by Merck. Ervebo has been highly effective at preventing the Ebola virus and stopping the infection. Ebola is a highly contagious disease and can be transmitted through close contact with an infected person.
Related Articles
The post World’s First-Ever Ebola Vaccine Gets FDA Approval appeared first on Latest Health & Medical News – Myhealthyclick.com.